# US 2016/0355523 A1 · Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355523 A1
- Document ID: US20160355523A1
- Status: Published application
- Kind: A1
- Application number: 15/172,860
- Filed: 2016-06-03
- Published: 2016-12-08
- Earliest claimed: 2015-06-05
- Assignees: Promega Corporation
- Applicants: Promega Corporation
- Inventors: Sergiy Levin; Rachel Friedman Ohana; Thomas Kirkland; Keith V. Wood
- Web page: https://patentgrep.com/patent/US20160355523A1

## CPC

- C07D 491/22: in which the condensed system contains four or more hetero rings
- A61P 35/02: specific for leukemia
- C07D 231/40: Acylated on said nitrogen atom
- C07D 487/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are cell-permeable, cell-compatible, and chemoselectively-cleavable linkers for tethering (e.g., covalently) functional elements (e.g., a cellular interaction element and a capture element), and methods of use (e.g., intracellular capture and extracellular release of cellular targets) therewith.

## Claims

### Claim 1

A dual-function, cell-permeable, cell-compatible, chemoselectively-cleavable composition, comprising:
(a) a cellular interaction element;
(b) a capture element; and
(c) a linker covalently tethering the cellular interaction element to the capture element, wherein said linker comprises a chemoselectively cleavable moiety.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the cellular interaction element is a small molecule or peptide.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the capture element is a covalent substrate for an enzyme.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the capture element comprises a haloalkane group.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the capture element is an affinity element.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the chemoselectively cleavable moiety is selected from the group consisting of: an allyl-heteroatom group, a propargyl-heteroatom group

### Claim 7 (depends on 6)

The composition of claim 6, wherein the chemoselectively cleavable moiety comprises an allyl-heteroatom group selected from the group consisting of: allyl ether, allyl amine, allyl ester, allyl amide, allyl urea, allyl carbonate, and allyl carbamate.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the chemoselectively-cleavable moiety comprises an allyl carbamate group.

### Claim 9 (depends on 6)

The composition of claim 6, wherein the chemoselectively-cleavable moiety comprises a propargyl-heteroatom group selected from the group consisting of: propargyl ether, propargyl amine, propargyl ester, propargyl amide, propargyl urea, propargyl carbonate, and propargyl carbamate.

### Claim 10 (depends on 1)

The composition of claim 1, comprising the formula:
Z-L1-Y-L2-Q,
wherein Z is a cellular interaction element, Q is a capture element, wherein L1 and L2 are independently optionally present and are independent linker moieties, and Y is a chemoselectively-cleavable moiety.

### Claim 11 (depends on 1)

A method comprising:
(a) administering the dual-function, cell-permeable, cell-compatible, chemoselectively-cleavable composition of claim 1 to a cell;
(b) allowing binding of the cellular interaction element with a corresponding intracellular cellular target;
(c) lysing said cell to produce a cell lysate; and
(d) contacting the capture element with a surface immobilized capture agent.

### Claim 12 (depends on 10)

The method of claim 10, further comprising:
(e) contacting the chemoselectively-cleavable linker with a corresponding chemoselective agent, thereby releasing the cellular interaction element and the bound cellular target from the surface.

### Claim 13 (depends on 1)

A system comprising:
(a) the dual-function, cell-permeable, cell-compatible, chemoselectively-cleavable composition of claim 1; and
(b) one or more of:
(i) a cell,
(ii) a cellular target,
(iii) a surface-displayed capture agent, and
(iv) a chemoselective agent.

### Claim 14

A method comprising, contacting a chemoselectively-cleavable composition comprising a first molecular entity linked to a second molecular entity by a transition metal cleavable linker with a transition metal ion or a chemoselective agent capable of releasing a transition metal ion under conditions in which the cleavable linker is cleaved by the transition metal ion, and the first molecular entity is released from the second molecular entity.

### Claim 15 (depends on 14)

The method of claim 14, wherein the chemoselectively-cleavable moiety is selected from the group consisting of: an allyl-heteroatom group and a propargyl-heteroatom group,

### Claim 16 (depends on 15)

The method of claim 15, wherein the allyl-heteroatom group is selected from the group consisting of: allyl ether, allyl amine, allyl ester, allyl amide, allyl urea, allyl carbonate, and allyl carbamate.

### Claim 17 (depends on 16)

The method of claim 16, wherein the allyl-heteroatom group comprises an allyl carbamate group.

### Claim 18 (depends on 15)

The method of claim 15, wherein the chemoselectively cleavable moiety comprises a propargyl-heteroatom group selected from the group consisting of: propargyl ether, propargyl amine, propargyl ester, propargyl amide, propargyl urea, propargyl carbonate, and propargyl carbamate.

### Claim 19 (depends on 14)

The method of claim 14, wherein the transition metal is Pd or Ru.

### Claim 20 (depends on 14)

The method of claim 14, wherein said conditions comprise a proteinaceous environment.

### Claim at position 21

21-24. (canceled)

### Claim 25

A method comprising:
(a) administering to a cell lysate or biochemical composition, a composition comprising:
(i) an interaction element;
(ii) a capture element; and
(iii) a linker covalently tethering the interaction element to the capture element, wherein said linker comprises a chemoselectively cleavable moiety;
(b) allowing binding of the interaction element with a corresponding target;
(c) contacting the capture element with a surface immobilized capture agent.

### Claim 26 (depends on 25)

The method of claim 25, further comprising:
(d) contacting the chemoselectively-cleavable linker with a corresponding chemoselective agent, thereby releasing the interaction element and the bound target from the surface.
